C 37 (Stavudine 40 mg)

Pill imprint C 37 has been identified as Stavudine 40 mg.

Stavudine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Stavudine 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Stavudine

Imprint:

C 37

Strength:

40 mg

Color:

Orange

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Aurobindo Pharma

National Drug Code (NDC):

65862-0047

Inactive Ingredients:

microcrystalline cellulose
sodium starch glycolate type A potato
lactose anhydrous
magnesium stearate
gelatin
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
ferric oxide red
ferrosoferric oxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
68084-0460	Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.